 long-term follow-up elderli patient locoregion breast cancer tamoxifen thirteen women year locoregion breast cancer tamoxifen primari treatment minimum year complet respons women partial respons chang progress diseas progress diseas patient initi respons suitabl convent therapi actuari surviv rate cent patient cent initi complet respons seventi patient cent tamoxifen death recent follow-up tamoxifen altern treatment oper breast cancer women short term suitabl concurr diseas unwil surgeri low morbid rate tamoxifen need close follow-up medium long term sole primari treatment tamoxifen delay definit therapi